Bionova supports clients with end-to-end programs or discrete projects. Either way, our commitment is to exceed expectations.
FEBRUARY 1, 2023
Bionova Scientific initiates expansion project to quadruple GMP biologics manufacturing capacity
JANUARY 18, 2023
Bionova Scientific introduces James Glover, II as Chief Operating Officer
JULY 18, 2022
Bionova Featured in BioProcess Online Article on Biopharma Resiliency
JUNE 10, 2022
Cytiva features Bionova Scientific in Biopharma Resiliency Video Series
JUNE 1, 2022
Asahi Kasei Medical completes acquisition of Bionova Scientific
MAY 2, 2022
Bionova’s Darren Head Featured in Contract Pharma CEO Spotlight
APRIL 18, 2022
Bionova Scientific announces agreement to become part of the Asahi Kasei Group
NOVEMBER 4, 2021
BIOPROCESS INTERNATIONAL: Bionova opens $25m single-use plant in Fremont
OCTOBER 27, 2021
CONTRACT PHARMA: Bionova Scientific Opens Biologics Manufacturing Facility
OCTOBER 26, 2021
Bionova Unveils New Commercial-Ready GMP Biologics Manufacturing Center at Grand Opening Event
JULY 30, 2021
Bionova welcomes Brad Larson as Vice President of Manufacturing, Facilities & Engineering
APRIL 14, 2021
EVENT: Bionova to host roundtable at American Biomanufacturing Summit
NOVEMBER 16, 2020
Bionova Scientific secures first client commitment for GMP manufacturing
JULY 16, 2020
Bionova aims to launch commercial manufacturing by 2021 with new biologics plant (Fierce Pharma)
JULY 13, 2020
Bionova building CA manufacturing plant to feed biologics demand (BioProcess Insider)
JULY 9, 2020
Bionova Scientific breaks ground on new GMP biologics manufacturing center
MARCH 6, 2020
Bionova Scientific announces surge capacity available as COVID-19 hits industry output
DECEMBER 12, 2019
Q&A with Amy Kong, Co-Founder & CEO of Bionova Scientific (External)
JUNE 3, 2019
Great Point Partners Makes $22 Million Equity Commitment to Bionova Scientific